Overview
Updated 14 Jul 2026
Jonathan Z. Li, MD, is Associate Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital / Harvard Medical School. The public record shows 331 publications with 17,418 citations (h-index 59), centered on SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, COVID-19 Clinical Research Studies. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 8 companies, 12 NIH-funded awards (2012–2026).
- Most recent indexed publication: 2026 · Microbiology spectrum
- Top research focus: SARS-CoV-2 and COVID-19 Research
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 43 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 179.
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- Member
NIH COVID-19 Treatment Guidelines Panel
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →actg-impaact-lc.org ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Music Therapy for Oral Mucositis Pain in Pediatric Patients
Sponsor: University of California, San Francisco
InvestigatorNot, yet, recruitingNCT07653360 - Biomarkers to Predict Time to Plasma HIV RNA Rebound
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
InvestigatorCompletedNCT03001128 - FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
InvestigatorPhase 4CompletedNCT01777997
Industry payments
Updated 14 Jul 2026
8 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202510 payments
- Shionogi IncProgram year20251 payment
- Gilead Sciences, Inc.Program year20251 payment
NIH funding
Updated 14 Jul 2026
12 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:
- High-Definition Characterization of the Persistence and Perturbation of the HIV Reservoir
Brigham and Women'S Hospital
FY2026$1,645,054P01AI169768 - High-Definition Characterization of the Persistence and Perturbation of the HIV Reservoir: Project 1
Brigham and Women'S Hospital
FY2026$461,151P01AI169768 - High-Definition Characterization of the Persistence and Perturbation of the HIV Reservoir: Data Analytics & Modeling Core
Brigham and Women'S Hospital
FY2026$198,996P01AI169768
Congress activity
Updated 14 Jul 2026
2 congress contributions (2019) across AACR per OpenAlex. The most recent:
- Abstract 1538: Margetuximab mediates greater Fc-dependent anti-tumor activities than trastuzumab or pertuzumab in vitro
AACR (meeting unresolved)
AACR2019Co-author - Abstract 1560: Selection of a bispecific trivalent HER2 x CD137 TRIDENT format providing optimal tumor-anchored immune co-stimulation
AACR (meeting unresolved)
AACR2019Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Expansion of stemlike HIV-specific CD8(+) T cells and limited viral epitope diversity characterize durable posttreatment control of HIV.
Science translational medicine
2026 - Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses.
The Journal of infectious diseases
2026
Most-cited worksby citation count (OpenAlex)
- 01Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host1,383 citations2020
- 02
- 03
- 04Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing805 citations2020
- 05
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
75 Francis Street, Boston, MA 02115
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mghbwhid.hms.harvard.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mghbwhid.hms.harvard.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jonathanlilab.bwh.harvard.edu ↗
Editorial & leadership rolesjournal and society appointments
- Deputy Editor
Journal of Infectious Diseases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jonathanlilab.bwh.harvard.edu ↗ - Vice Chair
ACTG HIV Reservoirs and Eradication Transformative Science Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jonathanlilab.bwh.harvard.edu ↗ - Member
AIDS Clinical Trials Group (ACTG) Executive Committee (former)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →actg-impaact-lc.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jonathanlilab.bwh.harvard.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jonathanlilab.bwh.harvard.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jonathanlilab.bwh.harvard.edu ↗
Secondary affiliationsappointments beyond the home institution
- Director
Harvard/Brigham Virology Specialty Laboratory
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jonathanlilab.bwh.harvard.edu ↗ - Director
Harvard University Center for AIDS Research (CFAR) Clinical Core
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jonathanlilab.bwh.harvard.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →jonathanlilab.bwh.harvard.edu ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →contagionlive.com ↗
- Featured researcher
"Finding HIV's last bastion in the body", Science Magazine Podcast
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Scott Solomon, MD
Brigham and Women's Hospital
- 2,109
- publications
- 190
- h-index
- 13
- trials
Toni Choueiri, MD
Brigham and Women's Hospital
- 2,494
- publications
- 152
- h-index
- 12
- trials
Muthiah Vaduganathan, MD, MPH
Brigham and Women's Hospital
- 1,168
- publications
- 101
- h-index
- 1
- trial
Bartolome Celli, MD
Brigham and Women's Hospital
- 809
- publications
- 134
- h-index
- 2
- trials